Buprenorphine for the Anesthesiologist and Pain Physician
Registration for the live event has closed, but you can view the session at On-Demand CME.
Wednesday, August 26, 2020
7-8:15 pm ET
Members: $25; non-members: $50
Trainees (non-CME): $10
Currently few anesthesiologists and pain physicians initiate buprenorphine in patients suffering from opioid use disorder (OUD). Initiating buprenorphine in this period has the potential to save lives. Anesthesiologists and pain physicians frequently encounter patients with comorbid OUD, thus are uniquely positioned to act. Proving an overview of buprenorphine and specific guidance on its use during the perioperative, postoperative, and clinic setting will be valuable in preventing morbidity and mortality related to OUD.
- Pharmacological overview
- Buprenorphine in the perioperative setting
- Buprenorphine in the outpatient setting
- Buprenorphine in the treatment of chronic pain